We interrogated the TCGA database via the open-access analysis platform, GlioVis, to determine if upregulation of GRP78 and GRP94 is observed in GBM patients compared to non-tumor controls and if higher expression is clinically relevant to patient survival. This evidence concerns the gene HSP90B1 and neoplasm.